Pular para o conteúdo
Lúpus eritematoso cutâneo raro
ORPHA:535DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Início todas idadesHerança Complex

OBSOLETO. O lúpus eritematoso cutâneo (LEC) é uma doença autoimune que denota um espectro heterogêneo de manifestações clínicas que afetam a pele e pode ser dividido em 4 categorias: LEC agudo (LECA); LEC subagudo (LECS); LEC crônico (LECC; a forma mais diversa); e LEC intermitente (LECI). O LEC pode ocorrer isoladamente ou associado ao lúpus eritematoso sistêmico (LES).

Última verificação: Fonte: não verificado (1 pendência)Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

Mantido pelo Disease Twin100% com fonte · atualizado 05/06/2026Revisão médica pendente
Informacoes curadas por IA — podem conter imprecisoes

Visão geral

O Lúpus Eritematoso Cutâneo Raro é uma doença autoimune que afeta a pele, caracterizada por um espectro heterogêneo de manifestações clínicas. Pode ser dividido em quatro categorias principais: lúpus eritematoso cutâneo agudo (LECA), subagudo (LECS), crônico (LECC) e intermitente (LECI). A condição pode ocorrer isoladamente ou estar associada ao lúpus eritematoso sistêmico (LES).[1]

A prevalência estimada é de 1 a 5 casos para cada 10.000 pessoas na população geral.[1]

A doença pode se manifestar em qualquer faixa etária, desde o nascimento até a idade adulta avançada.[1]

Sinais e sintomas

Os sinais e sintomas variam conforme o subtipo de lúpus cutâneo. As lesões podem incluir manchas avermelhadas, descamativas ou em formato de disco, sensibilidade à luz solar (fotossensibilidade) e, em alguns casos, cicatrizes ou alterações na pigmentação da pele. A gravidade e a extensão das lesões são muito variáveis entre os pacientes.[1]

Causas genéticas

O Lúpus Eritematoso Cutâneo Raro tem uma herança do tipo multigênica e multifatorial, o que significa que a predisposição à doença envolve a interação de múltiplos genes com fatores ambientais. Até o momento, não há um gene específico identificado como causa única da condição.[1][2]

Diagnóstico

O diagnóstico é baseado na avaliação clínica das lesões de pele, na história do paciente e, frequentemente, na realização de biópsia cutânea para análise histopatológica. Exames laboratoriais podem auxiliar na diferenciação entre as formas cutâneas e o lúpus sistêmico. Não há testes genéticos específicos disponíveis para confirmar o diagnóstico.[1][2]

Tratamento e manejo

O manejo do Lúpus Eritematoso Cutâneo Raro inclui medidas de proteção solar rigorosas (uso de filtros solares de amplo espectro e roupas de proteção) e tratamento tópico ou sistêmico com medicamentos. No Brasil, o acesso a alguns tratamentos pode ser parcialmente coberto pelo Sistema Único de Saúde (SUS), conforme a avaliação médica e a disponibilidade regional.[1]

Tratamentos citados na literatura

A literatura científica menciona associações entre o Lúpus Eritematoso Cutâneo Raro e os seguintes fármacos, com base em mineração de dados (número de publicações entre parênteses): dexametasona (1), acetato de dexametasona (1) e fosfato sódico de prednisolona (1). Estas são associações observadas em estudos, e não recomendações de tratamento. Consulte sempre seu médico para decisões terapêuticas.[1]

Prognóstico e qualidade de vida

O prognóstico varia conforme a extensão das lesões e a resposta ao tratamento. Muitos pacientes apresentam melhora significativa com o manejo adequado, especialmente com a proteção solar e o uso de medicamentos. A qualidade de vida pode ser impactada pelas lesões visíveis e pela fotossensibilidade, mas o acompanhamento médico regular ajuda a controlar os sintomas e a prevenir complicações.[1]

Fontes numeradas em Referências.

Conteúdo informativo gerado e mantido automaticamente a partir de fontes oficiais (Orphanet, HPO, OMIM, SUS). Não substitui avaliação médica.

💬
EM LINGUAGEM SIMPLES

O **lúpus eritematoso cutâneo raro** é uma condição autoimune que provoca alterações e lesões variadas na pele. O quadro pode se manifestar de maneiras distintas, como formas agudas, subagudas, crônicas ou intermitentes, em pessoas de qualquer idade. As lesões podem aparecer apenas na pele ou surgir em conjunto com o comprometimento de outros órgãos pelo lúpus eritematoso sistêmico. No Brasil, o SUS oferece suporte com fornecimento do medicamento **azatioprina** por meio do CEAF para os casos indicados.

Informacoes curadas por IA — podem conter imprecisoes
[1] Orphanet [18] CEAF (Componente Especializado da Assi…
📋
Informacoes curadas por IA — podem conter imprecisoes

OBSOLETO. O lúpus eritematoso cutâneo (LEC) é uma doença autoimune que denota um espectro heterogêneo de manifestações clínicas que afetam a pele e pode ser dividido em 4 categorias: LEC agudo (LECA); LEC subagudo (LECS); LEC crônico (LECC; a forma mais diversa); e LEC intermitente (LECI). O LEC pode ocorrer isoladamente ou associado ao lúpus eritematoso sistêmico (LES).

Medicamentos
1 com registro
Azatioprina

Tem tratamento?

✓ 1 medicamento específico desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
AZATIOPRINA

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
50.0
Europe
Início
All ages
🏥
SUS: Cobertura parcialScore: 50%
1 medicamento CEAF
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202571 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Lúpus eritematoso cutâneo raro

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
0 papers (10 anos)
#1

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

JAMA dermatology2026 Jan 01

Immune-mediated inflammatory diseases are rare but increasingly reported among patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). Systemic lupus erythematosus (LE) and cutaneous LE associated with MDS/CMML have been rarely described, with atypical features and refractory disease. To provide a comprehensive description of the phenotype and therapeutic responses of LE associated with MDS/CMML and to compare them with idiopathic LE. This retrospective case-control study included nationwide, multicenter data from January 1975 to January 2023. Patients with MDS/CMML who either fulfilled classification criteria for systemic LE or had skin lesions diagnosed as cutaneous LE were included. For MDS/CMML systemic LE, a 2:1 case-control study was conducted with idiopathic systemic LE. Clinical features, centralized skin histopathology, and targeted next-generation sequencing were analyzed. Data were analyzed from May 2022 to June 2025. The clinical, pathological, and molecular features of LE occurring in the setting of MDS or CMML compared with idiopathic LE. Of 24 included patients, 9 (38%) were female, 15 (63%) were male, and the median (range) age at diagnosis was 65 (32-85) years. A total of 19 were diagnosed with systemic LE and 5 with cutaneous LE. The median (range) follow-up was 4.5 (1-31) years. Cutaneous involvement was the most common manifestation of LE (17 [71%]). Chilblain lupus was the predominant subtype (6 [35%]). Compared with idiopathic systemic LE, patients with MDS/CMML-associated LE were older (median [range] age, 65 [32-85] years vs 23 [11-55] years; P < .001), more frequently male (10 [53%] vs 3 [8%]; P = .008), had less kidney involvement (2 [10%] vs 27 [71%]; P < .001), had less articular involvement (7 [36%] vs 37 [97%]; P < .001), and had reduced anti-double-stranded DNA positivity (6 [32%] vs 29 [76%]; P = .001). The underlying hematologic diseases included MDS (16 [66%]) and CMML (8 [34%]), with 22 (92%) classified as lower risk (Revised International Prognostic Scoring System score of 3.5 or less). Centralized histopathological review reclassified 6 skin biopsies (50%) as MDS/CMML cutis. Identical myeloid variants were detected in blood and skin in 6 of 8 patients, supporting a clonal inflammatory process. Standard LE therapies were often poorly effective, while clone-directed therapies (azacitidine or allogeneic hematopoietic stem cell transplant) led to parallel hematologic and LE responses in 5 of 7 patients. In this study, MDS/CMML-associated lupuslike manifestations were a distinct entity mimicking systemic LE or cutaneous LE and characterized by clonal inflammation rather than classic autoimmunity in most cases. Early recognition is important, as treatment may require clone-targeting therapies rather than conventional LE therapy.

#2

Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review.

Immunity, inflammation and disease2026 Mar

Patients with autoimmune disorders are highly susceptible to infections including cytomegalovirus (CMV) leading to serious complications ranging from asymptomatic to severe systemic diseases. The first case was a 44-year-old woman with systemic lupus erythematosus (SLE) referred to the Rheumatology ward due to a necrotizing ulcer on the hand's finger and multiple ulcerative lesions on her lips and tongue. She had pancytopenia and tested positive for both herpes simplex virus (HSV) and CMV polymerase chain reaction (CMV-PCR). She was treated with ganciclovir for 14 days and subsequently recovered. The second case was a 55-year-old man, a known sarcoidosis case, admitted to the hospital due to lower extremities weakness and intraoral ulcers. The lab findings revealed leukopenia and elevated levels of ESR and CRP. Viral markers were all negative except for the CMV-PCR test. Electromyography and nerve conduction velocity (EMG-NCV) showed subacute axonal motor polyneuropathy in the lower limbs. Due to the high titers of CMV (500,000 copies/mL), he was treated with ganciclovir for 2 weeks and the symptoms improved dramatically. CMV infection in patients with inflammatory rheumatic diseases may lead to rare manifestations that can be misdiagnosed as a flare of the underlying disease.

#3

Bullous Systemic Lupus Erythematosus in a Southeast Asian Cohort: High Systemic Association Driving Systemic Therapy.

Asian Pacific journal of allergy and immunology2026 Mar 14

Bullous systemic lupus erythematosus (BSLE) is a rare autoimmune blistering disorder occurring in association with systemic lupus erythematosus (SLE). Owing to its rarity, current knowledge remains limited, particularly in Southeast Asian populations. This study retrospectively evaluated the clinical, histopathologic, immunofluorescence, and serologic features of BSLE, together with a review of the existing literature. This review included patients diagnosed with BSLE at Siriraj Hospital, Mahidol University, between 2003 and 2024. Among 9,055 patients with cutaneous lupus erythematosus, 12 were identified as having BSLE (incidence 0.13%). The median age was 39.5 years with equal sex distribution. Most patients (75%) presented with BSLE at the time of SLE diagnosis, while others developed it later. Lesions appeared on sun-exposed and non-sun-exposed areas, mainly the extremities, and mucosal involvement occurred in 33.3%. Direct immunofluorescence most frequently demonstrated immunoglobulin (Ig) G deposition (91.7%), followed by complement 3 (83.3%), IgM (75%), and IgA (50%), typically with linear and/or granular deposition of IgG and C3 along the basement membrane zone. Antinuclear antibodies were present in all patients. Systemic involvement was common (75%), most frequently affecting the kidneys (66.7%), followed by hematologic abnormalities (58.3%). Owing to disease severity, most patients required treatment with systemic corticosteroids in combination with immunosuppressive agents rather than dapsone alone to achieve disease control. This study and literature review highlight that, although BSLE is an uncommon cutaneous manifestation of SLE, it is strongly associated with systemic involvement, particularly renal and hematologic disease, which often necessitates treatment with immunosuppressive agents.

#4

Skin-Limited Neonatal Lupus in an Infant Conceived by In Vitro Fertilization and Surrogate Gestation.

Pediatric dermatology2026 Mar 09

Neonatal lupus erythematosus (NLE) is a rare autoimmune condition caused by the transplacental passage of maternal anti-Ro/SSA and anti-La/SSB antibodies, typically presenting with annular erythema or congenital heart block. We report a 3-month-old infant conceived by in vitro fertilization and carried by a surrogate mother who developed annular erythematous plaques in typical and atypical locations at 1 month of age. Skin biopsy and serologic testing confirmed NLE despite the absence of a known maternal autoimmune history; maternal anti-Ro/SSA and anti-La/SSB positivity was identified retrospectively through the surrogate's obstetrician. The cutaneous findings improved significantly with photoprotection and resolved without systemic involvement.

#5

Erythroderma-Like Manifestations and High Fever in Palisaded Neutrophilic and Granulomatous Dermatitis Without Any Underlying Systemic Immunological Disease.

The Journal of dermatology2026 Mar 08

Palisaded neutrophilic and granulomatous dermatitis (PNGD) is a reactive granulomatous dermatitis; the umbrella term includes interstitial granulomatous dermatitis and interstitial granulomatous drug reaction, in addition to PNGD. The histological findings of PNGD include leukocytoclastic vasculitis, neutrophilic infiltrates, and collagen degeneration with palisades of histiocytes and small granulomas. Clinically, the patients show symmetrical, smooth papules that are skin-colored to red, some with central umbilication or crusting, located mainly on the elbows and extremities. PNGD usually occurs with some systemic diseases, such as systemic lupus erythematosus, suggesting a cutaneous reaction pattern due to underlying internal inflammation. Although the present case was histologically diagnosed as PNGD, while excluding other granulomatous diseases, multiple indurated erythematous papules with a tendency to coalesce widely were seen, mimicking erythroderma without any underlying immunological diseases. In addition, the eruption coincided with fluctuating high fever. This was a rare case of PNGD with no underlying immunological disease that presented with severe manifestations such as fever and erythroderma.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review.

Immunity, inflammation and disease
2026

Bullous Systemic Lupus Erythematosus in a Southeast Asian Cohort: High Systemic Association Driving Systemic Therapy.

Asian Pacific journal of allergy and immunology
2026

Skin-Limited Neonatal Lupus in an Infant Conceived by In Vitro Fertilization and Surrogate Gestation.

Pediatric dermatology
2026

Erythroderma-Like Manifestations and High Fever in Palisaded Neutrophilic and Granulomatous Dermatitis Without Any Underlying Systemic Immunological Disease.

The Journal of dermatology
2026

Photosensitive psoriasis mimicking cutaneous lupus erythematosus: a case report.

Dermatology reports
2026

Systemic Manifestations of Neonatal Lupus in an Infant Born to an Asymptomatic Mother: A Case Report of Anemia and Transaminitis.

The American journal of case reports
2026

A Diagnostic Pitfall: Lupus Mastitis Presenting Before Diagnosis of Systemic Lupus Erythematosus.

Case reports in rheumatology
2026

Labial adhesions as a rare mucosal manifestation of bullous lupus erythematosus in a 15-year-old female.

International journal of women's dermatology
2026

Twin Presentation of Cutaneous Neonatal Lupus Associated With Maternal Anti-U1RNP Antibodies: A Case Report.

Cureus
2026

Fulminant neuropsychiatric lupus leading to brain death: a case report.

AME case reports
2026

Chilblain lupus: A rare form of cutaneous lupus erythematosus - A case report.

SAGE open medical case reports
2025

A Case Report of a Rare Subacute Cutaneous Lupus Erythematosus with Chin Prostration.

Clinical, cosmetic and investigational dermatology
2025

Calcinosis Cutis in a Patient With Systemic Lupus Erythematosus: A Case Report.

Cureus
2025

Xanthomatous Discoid Lupus Erythematosus: An Unusual Histopathological Variant and Review of Reported Cases.

Cureus
2025

An Overview of the Pathogenesis of Cutaneous Lupus Erythematosus.

Journal of clinical medicine
2025

Chronic Cutaneous Lupus Erythematosus Presenting as Acne Scars: A Case Report.

Case reports in dermatology
2026

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

The Journal of rheumatology
2025

Overlap of Toxic Epidermal Necrolysis (TEN)-Like Cutaneous Lupus and Rowell Syndrome in Systemic Lupus Erythematosus: A Case-Based Review.

Cureus
2025

Sweet's Syndrome as a Prodromal Manifestation of Acute Myeloid Leukemia.

International journal of hematology-oncology and stem cell research
2026

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

JAMA dermatology
2026

Skin Disorders in Kidney Disease: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

African-ancestry-specific variant IKKβ p.Glu502Lys confers high lupus risk.

Nature genetics
2025

A Rare Case of Actinomycosis in a Patient With Systemic Lupus Erythematosus.

Cureus
2025

Koebner Phenomenon Induced by Eyeglasses in a Patient With Discoid Lupus Erythematosus.

Case reports in dermatological medicine
2025

Lupus pneumonitis in neonatal lupus: a case report.

Journal of medical case reports
2025

A Case Report of Atypical Presentation of Systemic Lupus Erythematosus in a Young Child.

International journal of rheumatic diseases
2025

Primary cutaneous mucinoses in connective tissue diseases as a diagnostic and prognostic challenge.

Clinics in dermatology
2025

[Hypocomplementemic urticarial vasculitis in SLE: between urticaria and autoimmunity].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

Characterisation of systemic lupus erythematosus associated with immune checkpoint inhibitors: a pharmacovigilance study using FAERS database.

Lupus science &amp; medicine
2025

Comedogenic Lupus in a 13-Year-Old Female: A Unique Pediatric Case.

Pediatric dermatology
2025

Lupus retinopathy manifesting unilateral neovascular alterations: A case with 15 years of follow-up.

American journal of ophthalmology case reports
2025

String-of-pearls: Extensive medium vessel vasculitis associated with childhood lupus.

Lupus
2025

Lupus Panniculitis of the Scalp Presenting as a Patchy Nonscarring Alopecia: Report of an Uncommon Case.

The American Journal of dermatopathology
2025

Methotrexate-Induced Leukocytoclastic Vasculitis: A Case Report and Literature Review.

Clinical, cosmetic and investigational dermatology
2026

A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus.

The Journal of rheumatology
2025

Urticarial hypocomplementemic vasculitis syndrome and systemic lupus erythematosus: a case report and review of the literature.

Frontiers in immunology
2025

Isolated Myositis Unveiling Systemic Lupus Erythematosus: A Rare Initial Presentation.

Cureus
2025

Isotopic Responses Following Herpes Zoster.

Journal of drugs in dermatology : JDD
2025

Treatment of systemic lupus erythemus overlap syndrome with autoimmune hepatitis using a combination of glucocorticoids and immunosuppressive agents: Case report.

Medicine
2025

Cutaneous mucormycosis: Unveiling rare manifestations.

Journal of family medicine and primary care
2025

Recognizing ophiasis pattern in discoid lupus: a rare diagnostic challenge.

Dermatology reports
2025

Erythema Multiforme-Like Lesions Revealing Systemic Lupus Erythematosus.

Cureus
2025

A textured clinical mosaic involving autoimmune calcific constrictive pericarditis: a case report.

European heart journal. Case reports
2024

A Case of Rowell Syndrome: Excellent Response to Oral Cyclosporine.

Acta dermatovenerologica Croatica : ADC
2025

Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohort.

Lupus science &amp; medicine
2025

Cutaneous Adverse Effects of Hydroxychloroquine and Leflunomide in Connective Tissue Diseases: A Report of Three Cases and a Literature Review.

Cureus
2025

A case of vitiligo secondary to discoid lupus erythematosus treated with tofacitinib.

Medicine
2025

Positive Direct Immunofluorescence in Rowell Syndrome: Further Support for a Subtype of Cutaneous Lupus Erythematosus.

Cureus
2025

Neonatal herpes simplex virus infection combined with neonatal lupus erythematosus: a case reported.

Frontiers in pediatrics
2025

Systemic Lupus Erythematosus and Psoriasis Overlap: A Case Series.

Cureus
2025

Subcutaneous Panniculitis-Like T-Cell Lymphoma With Increased γδ T Cells: A Potential Diagnostic Pitfall.

The American Journal of dermatopathology
2024

Bullous herpes zoster in a patient with bullous systemic lupus erythematosus.

Dermatology online journal
2025

Association of truncal involvement in lupus erythematosus panniculitis patients with calcinosis cutis: A retrospective cohort study.

Lupus
2025

Porphyria cutanea tarda and systemic lupus erythematosus: a case report.

Journal of medical case reports
2025

Vulval ulceration as a first presentation of systemic lupus erythematosus: A case report and literature review.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2025

Progressive repigmentation of hypopigmented lesions in discoid lupus erythematosus with anifrolumab: A report of two cases.

Lupus
2025

Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and Management.

Cureus
2025

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report.

Frontiers in immunology
2025

Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection.

Cureus
2025

Hydroxychloroquine-Induced Skin Hyperpigmentation in Systemic Lupus Erythematosus Patient: A Case Report.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2025

CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease.

Med (New York, N.Y.)
2026

Bilateral Periorbital Erythema and Swelling as an Initial Presentation of Systemic Lupus Erythematosus: A Rare Case.

Current rheumatology reviews
2025

Reversible dilated cardiomyopathy in systemic lupus erythematosus: A case report.

Lupus
2025

A novel STING1-activating mutation is identified in a patient with childhood-onset systemic lupus erythematosus.

Clinical immunology (Orlando, Fla.)
2025

Feline immune-mediated skin disorders: Part 1.

Journal of feline medicine and surgery
2025

Feline immune-mediated skin disorders: Part 2.

Journal of feline medicine and surgery
2025

Comedonal Plaques With Scarring Alopecia on the Scalp: A Case Report.

Cureus
2025

Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus With Histiocytic Necrotizing Lymphadenitis: A Case Report.

Cureus
2025

A case of necrotizing fasciitis secondary to cutaneous tuberculosis in a patient with systemic lupus erythematosus (SLE).

Annals of medicine and surgery (2012)
2025

Imaging Findings of Lupus Mastitis: A Systematic Review of Case Studies.

Cureus
2025

Case Report: Siblings with neonatal lupus erythematosus.

Frontiers in pediatrics
2025

Neonatal lupus erythematosus: an acquired autoimmune disease to be taken seriously.

Annals of medicine
2025

The Frequency of Non-Scarring Alopecia in Autoimmune Connective Tissue Diseases.

Journal of drugs in dermatology : JDD
2025

Dermatosis Neglecta and Chilblain Lupus Erythematosus Occurred Post Surgery of Basal Cell Carcinoma: A Case Report.

Clinical, cosmetic and investigational dermatology
2025

Pediatric Kikuchi-Fujimoto Disease: Case Report and Review of Cutaneous and Histopathologic Features in Childhood.

Dermatopathology (Basel, Switzerland)
2025

Clinical, Histopathological, and Therapeutic Features in Lupus Erythematosus Tumidus: A Retrospective Study.

Actas dermo-sifiliograficas
2025

Rare presentation of hypocomplementaemic urticarial vasculitis syndrome (HUVS) overlapping with systemic erythematosus lupus (SLE) and small lymphocytic lymphoma (SLL).

BMJ case reports
2025

Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.

Journal of nephrology
2025

Senear-Usher Syndrome or Coexistence of SLE with Pemphigus Vulgaris-A Case Report with Literature Review.

Journal of clinical medicine
2025

The Cutaneous Pathology of Erythromelalgia and Its Role in Establishing Critical Clues Regarding Pathogenesis.

The American Journal of dermatopathology
2025

Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review.

Human vaccines &amp; immunotherapeutics
2025

An Uncommon Presentation of Tumid Lupus Erythematosus Manifesting As Annular, Non-scarring Alopecia on the Scalp.

Cureus
2024

Phototoxic reaction to oral terbinafine due to Tinea capitis in a child.

Acta dermatovenerologica Croatica : ADC
2025

Case report: Diagnostic challenges of papulonodular mucinosis in a 67-year-old female.

SAGE open medical case reports
2025

Papulonodular mucinosis: a systematic review on clinicopathologic characteristics, course and treatment options.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2024

An Unusual Presentation of Cutaneous Bullous Lupus.

Cureus
2024

Macrophages in inflammatory skin diseases and skin tumors.

Frontiers in immunology
2024

[Systemic lupus erythematosus involving the fornix column leading to hyponatremia: A case report].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2025

Neonatal lupus erythematosus: 24 years of experience from a tertiary centre at Chandigarh, North India.

Lupus
2024

[Lupus Cheilitis: a clinical case report].

Revista medica del Instituto Mexicano del Seguro Social
2025

Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus.

American journal of clinical dermatology
2025

Histopathologic Comparisons of Discoid Lupus Erythematosus and Folliculotropic Mycosis Fungoides in a Series of 43 Cases.

Journal of cutaneous pathology
2024

Bullous Cutaneous Lupus Erythematosus and Class V Lupus Nephritis: Rare Concurrence.

European journal of rheumatology
2024

Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.

Archives of dermatological research
2024

Progressive lower extremity cellulitis in a patient with systemic lupus erythematosus on systemic immunosuppression: A rare manifestation of cutaneous tuberculosis.

JAAD case reports
2024

Lupus Mastitis: The Rare Mimic of Breast Malignancy.

Journal of breast imaging
2024

Complicated Mucocutaneous Leishmaniasis With Superimposed Cellulitis in an Immunocompromised Patient: A Case Report.

Cureus
2024

Unusual presentations in systemic lupus erythematosus with concurrent IgA nephropathy lesion: a rare case report from Eastern Nepal.

Annals of medicine and surgery (2012)
2024

Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI.

RMD open
2024

Histopathologic Overlap Between Bullous Lupus Erythematosus and Linear IgA Bullous Dermatosis: A Comparative Study.

The American Journal of dermatopathology
2024

Monogenic lupus - from gene to targeted therapy.

Molecular and cellular pediatrics
2024

Fever, convulsions, and rash: a case report of neonatal lupus erythematosus with macrophage activation syndrome.

Frontiers in pediatrics
2024

Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation.

Journal of clinical immunology
2024

Unveiling the Tempest: Dermal Plasmacytoid Dendritic Cell Proliferation as the Harbinger of Acute Myeloid Leukemia.

The American Journal of dermatopathology
2024

A case of Rowell syndrome after a herpes simplex infection and prolonged sun exposure.

Skin health and disease
2025

Monogenic lupus with neuroregression in an infant due to rare compound heterozygous variants in C1QA gene: Case-based review.

Modern rheumatology case reports
2024

Line-field confocal optical coherence tomography: Characteristic hints for the diagnosis of scarring alopecia due to lupus erythematodes: A preliminary study.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
2024

The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide.

Current medical research and opinion
2024

Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions.

Cureus
2024

Neonatal lupus erythematosus presenting with effusions: A 13-year retrospective study.

Clinical rheumatology
2025

Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series.

Actas dermo-sifiliograficas
2024

Lupus Erythematosus Tumidus Misdiagnosed as Erythema Nodosum from Coccidioidomycosis.

Case reports in dermatology
2024

Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report.

Dermatology reports
2024

Cluster analysis of clinical manifestations assigns systemic lupus erythematosus-phenotype subgroups: A multicentre study on 440 patients.

Joint bone spine
2024

Systemic Lupus Erythematosus Complicated with Mycobacterium Leprae Infection: a Rare Case Report.

Clinical laboratory
2024

Unraveling the diagnostic odyssey: stimulator of interferon gene-associated vasculopathy with onset in infancy in a 30-year-old female.

Journal of rheumatic diseases
2024

Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.

The Journal of rheumatology
2024

Hematological manifestation of Pediatric Systemic Lupus Erythematosus (SLE) - A single centered cross-sectional study.

Journal of family medicine and primary care
2024

Subcutaneous panniculitis-like T-cell lymphoma and lupus erythematosus profundus: a diagnostic dilemma.

BMJ case reports
2024

Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.

BMJ case reports
2024

Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.

The Journal of experimental medicine
2024

Development of bullous systemic lupus erythematosus in patient treated with NB-UVB: A case report and comprehensive review of the literature.

Clinical case reports
2024

Immune-mediated Equine Vasculopathies.

The Veterinary clinics of North America. Equine practice
2024

Navigating the diagnostic maze: A case presentation of C1q vasculitis mimicking hypocomplementemic urticarial vasculitis in a patient with systemic lupus erythematosus.

Lupus
2024

Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort.

Open heart
2024

Human-multimodal deep learning collaboration in 'precise' diagnosis of lupus erythematosus subtypes and similar skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV
2024

Tumid Lupus Erythematosus (TLE): A Review of a Rare Variant of Chronic Cutaneous Lupus Erythematosus (cCLE) with Emphasis on Differential Diagnosis.

Diagnostics (Basel, Switzerland)
2024

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario.

International journal of surgical pathology
2024

Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.

Respirology (Carlton, Vic.)
2024

A Case of Hydroxychloroquine Toxicity as Evidenced by Visual Field Changes.

Cureus
2023

Atorvastatin-induced Lupus Erythematosus Tumidus: A Case Report and Literature Review.

Acta dermatovenerologica Croatica : ADC
2024

Systemic lupus erythematosus associated with HIV infection: a retrospective case-control study.

Clinical and experimental rheumatology
2024

Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis.

Orphanet journal of rare diseases
2024

Neonatal lupus erythematosus as a rare trigger of gastrointestinal involvement in neonates.

Scientific reports
2024

Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease.

International journal of molecular sciences
2024

Exploring the Perspectives of Patients Living With Lupus: Retrospective Social Listening Study.

JMIR formative research
2023

A Case of Subcutaneous Panniculitis-Like T-cell Lymphoma With Hemophagocytic Lymphohistiocytosis in an HIV Patient.

Cureus
2024

A rare case of cutaneous lupus erythematosus presenting with periorbital erythema and edema.

Lupus
2023

Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report.

Frontiers in immunology
2023

Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD.

RMD open
2023

The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study.

Frontiers in medicine
2023

Lupus panniculitis as the initial presentation of systemic lupus erythematosus triggered by COVID-19 infection: case report and literature review.

Oxford medical case reports
2023

Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome.

Cureus
2023

Cornu Cutaneum: Case Reports of Patients With a Cutaneous Horn Associated With Either a Verruca Vulgaris or an Inverted Follicular Keratosis and a Review of the Etiologies of Cutaneous Horns.

Cureus
2023

Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature.

Biomedicines
2023

A Rare Manifestation of Discoid Lupus Erythematosus Solely in the Lower Eyelid of a Young Man.

Cureus
2023

Thrombosis and APS: Lessons Learned from Another Black Swan Tale.

Lupus
2024

Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.

The British journal of dermatology
2023

Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil.

Cureus
2024

High-risk groups of neonatal lupus erythematosus in term infants: a birth cohort study.

European journal of pediatrics
2023

Risk Factors for Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus: A Systematic Review and Expert Consensus.

ACR open rheumatology
2023

Lupus Erythematosus Profundus with Multiple Overlying Cutaneous Ulcerations: A Rare Case.

Clinical, cosmetic and investigational dermatology
2023

Subacute cutaneous lupus erythematosus with a psoriasiform presentation: A diagnostic clinical conundrum.

Clinical case reports
2023

Guideline for allergological diagnosis of drug hypersensitivity reactions: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in cooperation with the German Dermatological Society (DDG), the Association of German Allergologists (ÄDA), the German Society for Pediatric Allergology (GPA), the German Contact Dermatitis Research Group (DKG), the German Society for Pneumology (DGP), the German Society of Otorhinolaryngology, Head and Neck Surgery, the Austrian Society of Allergology and Immunology (ÖGAI), the Austrian Society of Dermatology and Venereology (ÖGDV), the German Academy of Allergology and Environmental Medicine (DAAU), and the German Documentation Center for Severe Skin Reactions (dZh).

Allergologie select
2024

Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Arthritis care &amp; research
2023

Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis.

Autoimmunity reviews
2024

Amicrobial pustulosis of the folds: A case report of a rare variant of neutrophilic dermatosis associated with systemic lupus erythematosus.

Journal of cutaneous pathology
2023

Non-scarring alopecia of lupus erythematosus: A comprehensive review.

Annales de dermatologie et de venereologie
2023

Neonatal lupus erythematosus manifested as a complete heart block: A case report.

Clinical case reports
2023

Reticular Erythematous Mucinosis in an African Woman with HIV Infection: Case Report and Literature Review.

Case reports in dermatology
2023

An Uncommon Presentation of Neonatal Lupus Erythematosus: A Case Report.

Case reports in dermatology
2023

Kikuchi-Fujimoto disease: A comprehensive review.

World journal of clinical cases
2023

[Neonatal lupus erythematosus, a clinical case].

Andes pediatrica : revista Chilena de pediatria
2023

Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.

Canadian journal of anaesthesia = Journal canadien d'anesthesie
2023

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report.

Journal of medical case reports
2023

Ocular Discoid Lupus Erythematosus: More Than what Meets The Eye.

Indian dermatology online journal
2023

Neurological and endocrinological involvement in neonatal lupus erythematosus: a retrospective study at a tertiary hospital in Eastern China.

Clinical rheumatology
2023

Insights into the clinical presentation of juvenile systemic lupus erythematosus: the PRAGMA monocentric cohort of 177 patients.

Clinical and experimental rheumatology
2023

The Enigma of Autoimmunity: A Case of Subacute Sclerosing Panencephalitis in a Patient Diagnosed With Systemic Lupus Erythematosus.

Cureus
2023

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS).

Journal of personalized medicine
2023

Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.

BMC neurology
2023

Infliximab-Induced Lupus in a Patient With Psoriatic Arthritis Who Presented With Cardiac Tamponade: A Case Report.

Cureus
2023

Comedonic lupus, a rare variant of chronic cutaneous lupus erythematosus (CCLE): case series and literature review.

International journal of dermatology
2023

Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review.

Clinical, cosmetic and investigational dermatology
2023

Optimal combination of arsenic trioxide and copper ions to prevent autoimmunity in a murine HOCl-induced model of systemic sclerosis.

Frontiers in immunology
2023

Lupus panniculitis: a rare bilateral and symmetrical manifestation of cutaneous lupus erythematosus in an adolescent girl.

Dermatology reports
2023

A 30-Year-Old Woman with a History of Autoimmune Hyperthyroidism Presenting with Fever and Oral Ulcers, Diagnosed with Discoid Lupus Erythematosus.

The American journal of case reports
2023

Actinic Lichen Planus: Significance of Dermoscopic Assessment.

Cureus
2023

Systemic Lupus Erythematosus Lymphadenopathy Presenting as Kikuchi-Fujimoto Disease in an Adolescent.

Cureus
2023

Lenalidomide for systemic lupus erythematosus with refractory cutaneous eruptions.

Rheumatology (Oxford, England)
2023

Severe immune thrombocytopenia in two patients with systemic sclerosis.

Joint bone spine
2023

Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.

Italian journal of dermatology and venereology
2023

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus.

Journal of clinical medicine
2023

Intestinal Submucosal Mucinosis in a Patient With Systemic Lupus Erythematosus: A Case Report.

International journal of surgical pathology
2022

A crack in the armor: Wolf isotopic response manifesting as cutaneous lupus.

Dermatology online journal
2023

Sclerodermiform Lupus Erythematosus: A Series of Five Patients.

The Journal of clinical and aesthetic dermatology
2023

[Characteristics of the course of lupus erythematosus panniculitis in a retrospective analysis of 17 patients].

Orvosi hetilap
2023

Comedogenic lupus: a rare variant of chronic cutaneous lupus erythematosus - case series.

Anais brasileiros de dermatologia
2023

Mucocutaneous diseases with manifestations in the head and neck region: 24 years of experience in a Dermatology service.

Medicina oral, patologia oral y cirugia bucal
2022

A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination.

Case reports in dermatological medicine
2023

Unilateral lupus mastitis.

Lupus
2023

Neonatal lupus erythematosus presenting as a non-bullous histiocytoid neutrophilic dermatosis.

Journal of cutaneous pathology
2023

SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.

The Journal of dermatology
2023

A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection.

Journal of neurology
2022

Reactive perforating collagenosis and systemic lupus erythematosus: A rare case report.

Medicine
2023

Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.

JAMA dermatology
2022

Subcutaneous Panniculitis-like T-Cell Lymphoma with a Transformation to Lupus Erythematosus Panniculitis: A Case Report.

Case reports in dermatology
2022

Keratoderma in Systemic Lupus Erythematosus: An Unusual Cutaneous Manifestation of Disease?

Cureus
2022

Uncommon Non-Infectious Annular Dermatoses.

Indian journal of dermatology
2022

Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature.

Journal of clinical medicine

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Lúpus eritematoso cutâneo raro.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Lúpus eritematoso cutâneo raro e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Protocolo oficial relacionado (Ministério da Saúde)PCDT: Lúpus Eritematoso Sistêmico

Existe um documento oficial para "Lúpus Eritematoso Sistêmico". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.

Respostas geradas por IA a partir das fontes citadas

É uma doença autoimune caracterizada por manifestações clínicas que afetam a pele. Ela se divide em quatro formas principais: aguda, subaguda, crônica e intermitente.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

3 fontes citadas no texto · 10 publicações do grafo RarasNet (PubMed) · 3 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. MONDO
    purl.obolibrary.org
  2. Q18553226
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (2026). Lúpus eritematoso cutâneo raro. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/lupus-eritematoso-cutaneo-raro

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Lúpus eritematoso cutâneo raro

ORPHA:535 · MONDO:0018887
🇧🇷 Brasil SUS
CEAF
1BAzatioprina
Geral
Prevalência
1-5 / 10 000
Herança
Multigenic/multifactorial
Início
All ages
Prevalência
50.0 (Europe)
MedGen
UMLS
C0024137
Repurposing
3 candidatos
dexamethasone — glucocorticoid receptor agonist
dexamethasone-acetate
prednisolone-sodium-phosphate
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara